Business Standard

In near term, the business would require significant financial, strategic support, which may impact Exide till a new partner is roped in

M Saraswathy  |  Mumbai 

  • ALSO READ

    Exide to buy out partners' stake in ING Vysya Life

    Sequoia eyeing stake in Medimix maker, Cholayil

    Exide to buy out partners' stake in ING Vysya Life for Rs 550 cr

    ING exits life insurance business in India

    Everstone Capital picks Rs 220-crore stake in Transpole

Exide Industries' decision to buy out the partner stake in its insurance joint venture Life Insurance will strain its core operations, said a report by Edelweiss Securities. The company had yesterday said that it would increase its stake in the life insurance company to 100% by paying Rs 550 crore for the remaining 50% stake from the other partners including ING.

In a note to its clients, said that they have valued the life insurance company at 1.6X embedded value, whereas its peers are in the valuation range of 1.5-2X. It It added that since the transaction has been in-principle agreed upon at 1X embedded value, it is an attractive transaction for Exide.

However, it added that in the near term, the business would require significant financial and strategic support, which may impact Exide till a new partner is roped in. "The exit of ING/partners will lay the onus of supporting and running the business till such time a strategic partner is roped in. This can drag down the company's performance in the near term," Edelweiss Securities said in the note.

The brokerage said that while the exit of ING from the was long due and is positive post induction of a strategic partner, it added that the operations of the life insurance firm will require strategic and financial support till then. This commitment from Exide, according to the note, would strain its resources and managerial bandwidth. The brokerage has said that they maintain 'HOLD' for Exide with a target price of Rs 132.

Meanwhile, a report by Citi has downgraded Exide to sell, on account of its ING Vysya acquisition which is unrelated to core business. Citi said that the de-rating is due to the fact that this acquisition is completely unrelated, loss-making and could possibly require incremental funding, and is unlikely to find a purchaser. It added that they view it negatively and expect the stock to de-rate on the back of this event.

At 12.45 pm, the shares of traded at Rs 123.40 on the Bombay Stock Exchange, down 1.2% from previous day's close.

Exide's 100% stake in ING Vysya to strain core ops: Edelweiss Securities

In near term, the business would require significant financial, strategic support, which may impact Exide till a new partner is roped in

Exide Industries' decision to buy out the partner stake in its insurance joint venture ING Vysya Life Insurance will strain its core operations, said a report by Edelweiss Securities. The company had yesterday said that it would increase its stake in the life insurance company to 100% by paying Rs 550 crore for the remaining 50% stake from the other partners including ING.

Exide Industries' decision to buy out the partner stake in its insurance joint venture Life Insurance will strain its core operations, said a report by Edelweiss Securities. The company had yesterday said that it would increase its stake in the life insurance company to 100% by paying Rs 550 crore for the remaining 50% stake from the other partners including ING.

In a note to its clients, said that they have valued the life insurance company at 1.6X embedded value, whereas its peers are in the valuation range of 1.5-2X. It It added that since the transaction has been in-principle agreed upon at 1X embedded value, it is an attractive transaction for Exide.

However, it added that in the near term, the business would require significant financial and strategic support, which may impact Exide till a new partner is roped in. "The exit of ING/partners will lay the onus of supporting and running the business till such time a strategic partner is roped in. This can drag down the company's performance in the near term," Edelweiss Securities said in the note.

The brokerage said that while the exit of ING from the was long due and is positive post induction of a strategic partner, it added that the operations of the life insurance firm will require strategic and financial support till then. This commitment from Exide, according to the note, would strain its resources and managerial bandwidth. The brokerage has said that they maintain 'HOLD' for Exide with a target price of Rs 132.

Meanwhile, a report by Citi has downgraded Exide to sell, on account of its ING Vysya acquisition which is unrelated to core business. Citi said that the de-rating is due to the fact that this acquisition is completely unrelated, loss-making and could possibly require incremental funding, and is unlikely to find a purchaser. It added that they view it negatively and expect the stock to de-rate on the back of this event.

At 12.45 pm, the shares of traded at Rs 123.40 on the Bombay Stock Exchange, down 1.2% from previous day's close.

image

Latest News